TAGS, a randomized, double-blind, phase 3 study evaluating TAS-102 plus best supportive care vs placebo plus best supportive care in patients with metastatic gastric cancer refractory to standard treatments Meeting Abstract
| Authors: | Ilson, D. H.; Tabernero, J.; Shitara, K.; Winkler, R.; Nasermoaddeli, A.; Ding, C.; Doi, T. |
| Abstract Title: | TAGS, a randomized, double-blind, phase 3 study evaluating TAS-102 plus best supportive care vs placebo plus best supportive care in patients with metastatic gastric cancer refractory to standard treatments |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 240s |
| Language: | English |
| ACCESSION: | WOS:000404665406105 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.TPS4141 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS4141 -- Source: Wos |
